Last reviewed · How we verify
Beta-hCG
At a glance
| Generic name | Beta-hCG |
|---|---|
| Sponsor | Egymedicalpedia |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparison of Beta-hCG Levels When Using Venous Puncture Blood and Peripheral Finger Stick Blood
- Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer (NA)
- EARLY-PREG: A Preconception Cohort Study Based on Counterfactuals to Study Maternal-Embryonic Molecular Interactions
- MIRA CONNECT Study (NA)
- Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment (NA)
- Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia (NA)
- Beta-HCG Levels in Uterine Cavity Lavage for Pregnancies of Unknown Location (NA)
- Hormone Evaluation in Artificial Reproductive Technology (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Beta-hCG CI brief — competitive landscape report
- Beta-hCG updates RSS · CI watch RSS
- Egymedicalpedia portfolio CI